“After listing, premium valuations of Dr. Lal Pathlabs have expanded further due to its strong track record, healthy return ratios & high free cash flows despite the aggressive expansion & exponential growth in business,”:MOSL http://goo.gl/i9J0Rm

“After listing, premium valuations of Dr. Lal Pathlabs have expanded further due to its strong track record, healthy return ratios and high free cash flows despite the aggressive expansion and exponential growth in business,”:Motilal Oswal http://goo.gl/i9J0Rm
http://goo.gl/i9J0Rm